共 5 条
- [3] A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A6 - A6
- [4] Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: Results of a 12-month, single-blind, randomized, parallel-group, multicenter study JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (08): : 935 - 941
- [5] Safety and tolerability of enteric-coated mycophenolate sodium in combination with steroids and two regimen of Neoral®, in de novo kidney transplant recipients:: 6 months interim results.: A randomized, multicentre, open, prospective controlled study. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 219 - 219